Shopping Cart
- Remove All
- Your shopping cart is currently empty
LT175, a dual PPARα/γ ligand, demonstrates potent insulin-sensitizing effects with reduced adipogenic properties. This orally active partial agonist targets PPARγ with EC50 values of 0.22 μm for hPPARα, 0.26 μm for mPPARα, and 0.48 μm for hPPARγ. LT175 specifically interacts with PPARγ, influencing the recruitment of coregulators, such as the cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1), within a hydrophobic region known as the diphenyl pocket [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $78 | 35 days |
Description | LT175, a dual PPARα/γ ligand, demonstrates potent insulin-sensitizing effects with reduced adipogenic properties. This orally active partial agonist targets PPARγ with EC50 values of 0.22 μm for hPPARα, 0.26 μm for mPPARα, and 0.48 μm for hPPARγ. LT175 specifically interacts with PPARγ, influencing the recruitment of coregulators, such as the cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1), within a hydrophobic region known as the diphenyl pocket [1]. |
In vivo | LT175 (100 mg/kg/day, orally, for 3 days) significantly reduces body weight (11%) as well as fasting blood glucose, triglycerides, free fatty acids, and total plasma cholesterol in diet-induced insulin-resistant six-week-old C57Bl/6J male mice [1]. |
Molecular Weight | 318.37 |
Formula | C21H18O3 |
Cas No. | 862901-87-9 |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.